Cargando…

Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous‐Flow Left Ventricular Assist Devices

BACKGROUND: The presence of a durable left ventricular assist device (LVAD) is associated with increased risk of vasoplegia in the early postoperative period following heart transplantation (HT). However, preoperative predictors of vasoplegia and its impact on survival after HT are unknown. We sough...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asleh, Rabea, Alnsasra, Hilmi, Daly, Richard C., Schettle, Sarah D., Briasoulis, Alexandros, Taher, Riad, Dunlay, Shannon M., Stulak, John M., Behfar, Atta, Pereira, Naveen L., Frantz, Robert P., Edwards, Brooks S., Clavell, Alfredo L., Kushwaha, Sudhir S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915279/ https://www.ncbi.nlm.nih.gov/pubmed/31701791 http://dx.doi.org/10.1161/JAHA.119.013108

Ejemplares similares

Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation
por: Alnsasra, Hilmi, et al.
Publicado: (2019)

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022)

Outcomes after heart transplantation in patients with cardiac sarcoidosis
por: Asleh, Rabea, et al.
Publicado: (2022)

Left ventricular assist devices as destination therapy in stage D heart failure
por: Asleh, Rabea, et al.
Publicado: (2019)

Timing of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients
por: Asleh, Rabea, et al.
Publicado: (2018)

Vascular Function in Continuous Flow LVADs: Implications for Clinical Practice
por: Khalil, Fouad, et al.
Publicado: (2023)

Novel Left Heart Catheterization Ramp Protocol to Guide Hemodynamic Optimization in Patients Supported With Left Ventricular Assist Device Therapy
por: Rosenbaum, Andrew N., et al.
Publicado: (2019)

Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation
por: Alnsasra, Hilmi, et al.
Publicado: (2020)

Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
por: Asleh, Rabea, et al.
Publicado: (2018)

Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database
por: Kampaktsis, Polydoros N., et al.
Publicado: (2022)

Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease
por: Inampudi, Chakradhari, et al.
Publicado: (2018)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
por: Asleh, Rabea, et al.
Publicado: (2022)

Vasoplegia: A Review
por: Ratnani, Iqbal, et al.
Publicado: (2023)

The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)

National Trends in Admission and In‐Hospital Mortality of Patients With Heart Failure in the United States (2001–2014)
por: Akintoye, Emmanuel, et al.
Publicado: (2017)

Vasoplegia treatments: the past, the present, and the future
por: Levy, Bruno, et al.
Publicado: (2018)

Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass
por: Pasero, D., et al.
Publicado: (2020)

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
por: Muhammad, Rizal, et al.
Publicado: (2022)

Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
por: Briasoulis, Alexandros, et al.
Publicado: (2020)

State‐of‐the‐art machine learning improves predictive accuracy of 1‐year survival after heart transplantation
por: Kampaktsis, Polydoros N., et al.
Publicado: (2021)

Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience
por: Grupper, Avishay, et al.
Publicado: (2016)

Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms
por: Burgdorff, A.-M., et al.
Publicado: (2018)

The Use of Methylene Blue during Liver Transplantation for Vasoplegia
por: Harding, Paul, et al.
Publicado: (2021)

Commentary: Vasoplegia after aortic surgery: Looking for options
por: Serna-Gallegos, Derek, et al.
Publicado: (2020)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Vasoplegia during radical prostatectomy: Methylene blue to rescue
por: Manish, Tandon, et al.
Publicado: (2023)

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery
por: Bak, Marek A, et al.
Publicado: (2022)

The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
por: Papazisi, Olga, et al.
Publicado: (2020)

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation
por: Tecson, Kristen M., et al.
Publicado: (2018)

Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning
por: Saha, Biplab K., et al.
Publicado: (2020)

Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
por: Sovic, William, et al.
Publicado: (2021)

Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
por: Zurita‐Lizza, Christian Carlos, et al.
Publicado: (2022)

Commentary: Angiotensin II for vasoplegia: A desperate measure for desperate times
por: Balsam, Leora B.
Publicado: (2020)

Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
por: Ayasa, Laith A, et al.
Publicado: (2023)

Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration
por: Colson, Pascal H, et al.
Publicado: (2011)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

Case report on intravenous octreotide for the treatment of intraoperative vasoplegia following thymoma resection
por: Williams, Wendell H, et al.
Publicado: (2019)

Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair
por: Chatterjee, Subhasis, et al.
Publicado: (2020)

Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia
por: ten Lohuis, Caitlin C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3oikbjaddn9fe6rubb31ivgcs